Correlation Between Silo Pharma and Integral

Can any of the company-specific risk be diversified away by investing in both Silo Pharma and Integral at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Silo Pharma and Integral into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Silo Pharma and Integral Ad Science, you can compare the effects of market volatilities on Silo Pharma and Integral and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Silo Pharma with a short position of Integral. Check out your portfolio center. Please also check ongoing floating volatility patterns of Silo Pharma and Integral.

Diversification Opportunities for Silo Pharma and Integral

0.41

Correlation Coefficient

Silo Pharma  Integral

Very weak diversification

The 3 months correlation between Silo and Integral is 0.41. Overlapping area represents the amount of risk that can be diversified away by holding Silo Pharma and Integral Ad Science in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integral Ad Science and Silo Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Silo Pharma are associated (or correlated) with Integral. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integral Ad Science has no effect on the direction of Silo Pharma i.e., Silo Pharma and Integral go up and down completely randomly.

Pair Corralation between Silo Pharma and Integral

Given the investment horizon of 90 days Silo Pharma is expected to under-perform the Integral. In addition to that, Silo Pharma is 4.06 times more volatile than Integral Ad Science. It trades about -0.07 of its total potential returns per unit of risk. Integral Ad Science is currently generating about -0.11 per unit of volatility. If you would invest  1,085  in Integral Ad Science on September 21, 2024 and sell it today you would lose (41.00) from holding Integral Ad Science or give up 3.78% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	95.45%
Values	Daily Returns

Silo Pharma  vs.  Integral Ad Science

Silo Pharma

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Silo Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of abnormal performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in January 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Integral Ad Science

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Integral Ad Science has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Integral is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Silo Pharma and Integral

The main advantage of trading using opposite Silo Pharma and Integral positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Silo Pharma position performs unexpectedly, Integral can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integral will offset losses from the drop in Integral's long position.

The idea behind Silo Pharma and Integral Ad Science pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.